Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
European Investment Bank (HQ)

ANOCCA (IEU TI)

Last update: Dec 6, 2024 Last update: Dec 6, 2024

Details

Location:Sweden
Sweden
Category:Unspecified/Other
Status:Approval
Sectors:Health, Science & Innovation
Contracting authority: Anocca AB
Funding Agency:
European Investment Bank (HQ)
Contracting authority type:Consulting organization
Eligibility:Unknown
Budget: EUR 96,000,000
Date posted: Jan 24, 2023

Attachments • 0

Associated Awards

Project cycle timeline

STAGES
EARLY INTELLIGENCE
PROCUREMENT
IMPLEMENTATION
Cancelled
Status
Programming
Formulation
Approval
Forecast
Open
Closed
Shortlisted
Awarded
Evaluation

Description

Reference: 20220474 Release date: 23 January 2023 Promoter – Financial IntermediaryANOCCA AB LocationSweden DescriptionThe promoter's technologies enable highly precise and efficient analysis of T-cell immunity required to deliver a range of therapeutics
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits
Print